Dr. Miguel Fernández de Sanmamed Gutiérrez

Dr. Miguel Fernández de Sanmamed Gutiérrez, a distinguished medical oncologist based at Clínica Universidad de Navarra in Spain, is widely recognized for his expertise in the field of oncology with a focus on immunotherapy for skin tumors. With a career spanning 8 years, Dr. Fernández has earned a stellar reputation as a practitioner and a dedicated researcher. His educational journey includes primary medical and surgical education at the University of Santiago de Compostela, followed by a doctorate from the University of Oviedo. Additionally, he holds a specialization certificate in medical oncology from the Central University Hospital for Asturias, further enriching his qualifications. Dr. Fernández's professional trajectory began after completing his doctoral thesis at the University of Navarra Clinic. Notably, he served as a postdoctoral researcher in the immuno-biology program at Yale University, USA, from 2013 to 2018. Since 2018, he has been contributing his expertise as a medical oncologist at the University of Navarra Clinic, where he also holds the role of principal investigator for research on immunotherapy and skin tumors. His commitment to advancing clinical studies is evident in his adjunct professorship and the role of a visiting professor at the Complutense University of Madrid since 2020. Dr. Fernández is an active member of esteemed organizations, including the European Society for Medical Oncology, the Spanish Federation for Cancer Research, and the ESMO Clinical Research Task Force. With a prolific research portfolio, he has published over 70 articles in international journals and co-authored chapters in specialty books. His contributions have been acknowledged with awards such as the Annual Meeting Travel Award from the European Society for Medical Oncology and the Oral Communication Award from the Spanish Federation for Cancer Research. Remarkably, Dr. Fernández's publications have garnered substantial recognition, being cited 6,314 times, underscoring his significant impact on the field of oncology and immunotherapy.